| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V102943 | 12(S)-HETrE | 72710-10-2 | 12(S)-HETrE is a fatty acid metabolite that inhibits platelet aggregation. |
|
V1598 | A-205804 | 251992-66-2 | A-205804 (A205804; A 205804) is a novel selective inhibitor of E-selectin and intercellular adhesion molecule-1 (ICAM-1) expression (IC50 = 20 nM and 25 nM) with potential anticancer activity. |
|
V128352 | Adxanthromycin A | 223740-97-4 | Adxanthromycin A is a microbial metabolite and an ICAM-1/LFA-1 mediated cell adhesion inhibitor. |
|
V2992 | CWHM-12 | 1564286-55-0 | CWHM-12 isa novel potent small molecule inhibitor of αV integrins with IC50s of 1.8/0.8/1.5/0.2 nM for αvβ1/αvβ3/αvβ8. |
|
V110653 | Cyclic αvβ6 | 2089299-82-9 | Cyclic αvβ6 (compound c(FRGDLAFp(NMe)K)) is a cyclic nonapeptide that specifically targets αvβ6 integrin. |
|
V1601 | Cyclo(-RGDfK) | 161552-03-0 | Cyclo(-RGDfK) is a potent, selective and cyclo-peptide-based αvβ3 integrin inhibitor with potential antitumor activity. |
|
V56055 | Cyclo(Ala-Arg-Gly-Asp-Mamb) (XJ735) | 153381-95-4 | Cyclo(Ala-Arg-Gly-Asp-Mamb) is a selective RGD peptide antagonist that may be utilized in research on the treatment of pulmonary arterial hypertension. |
|
V135061 | Emvistegrast | 2417352-91-9 | Emvistegrast is a quinolone derivative. |
|
V135062 | Emvistegrast axial isomer | Emvistegrast axial isomer is an axial isomer of Emvistegrast. | |
|
V56056 | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro | 2022956-44-9 | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro is GRGDSP coupled to FITC . |
|
V111014 | FSC(PEG4-αvβ6)₃ | FSC(PEG4-avb6)3 is a tracer that targets αvβ6 integrin trimer (IC50 = 0.69 nM). | |
|
V21632 | GLPG0187 | 1320346-97-1 | GLPG0187 (GLPG-0187) is a novel, potent, broad spectrum and small molecule integrin receptor antagonist (IRA) with potential anticancer activity, inhibiting αvβ1-integrin with an IC50 of 1.3 nM. |
|
V140043 | MLN2201 | MLN2201 is a humanized monoclonal antibody inhibitor that targets integrin β2. | |
|
V56054 | Orbofiban | 163250-90-6 | Orbofiban is an orally bioactive platelet membrane glycoprotein IIb/IIIa antagonist that can inhibit platelet aggregation. |
|
V141969 | OS-2966 | OS-2966 is a humanized antibody expressed in CHO cells that targets integrin β1/ITGB1/CD29. | |
|
V144074 | RGD-DA6 | 3105965-82-7 | RGD-DA6 is a ligand that targets αvβ3. |
|
V144279 | Rondaptivon pegol | 2573048-75-4 | Rondaptivon pegol is a PEGylated form of aptamer BT100 that inhibits the binding of von Willebrand factor (VWF) to platelet glycoprotein GPIb, thereby preventing arterial thrombosis. |
|
V144280 | Rondaptivon pegol sodium | Rondaptivon pegol sodium is an aptamer that targets von Willebrand factor (VWF) with an EC50 of 33 nM in humans. | |
|
V144281 | Rondaptivon pegol sodium scrambled negative control | The Rondaptivon pegol sodium scrambled negative control is a negative control with the sequence of Rondaptivon pegol sodium scrambled. | |
|
V111339 | RTDLDSLRTYTL TFA | RTDLDSLRTYTL TFA is a high-affinity, high-specificity αvβ6 integrin (AVβ6) inhibitor. |